2026 NPPES data Plastic Surgery Physician NPI 1063435493 M.D.
Verify on CMS →

NAYIRI DOUDIKIAN-SCAFF, M.D.

Plastic Surgery Physician in PASADENA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
384
Medicare Part D claims · 89 beneficiaries · Plastic Surgery Physician avg: 84
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$244.71
12 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: NAYIRI DOUDIKIAN-SCAFF, M.D. is a Plastic Surgery Physician ([object Object]) practicing in PASADENA, California with a Medicare Part D prescribing footprint of 384 claims across 89 beneficiaries — 20% brand-name prescribing . Industry payments of $244.71 across 12 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: NAYIRI DOUDIKIAN-SCAFF, M.D. filed 384 Medicare Part D claims in 2023 across PASADENA, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

NAYIRI DOUDIKIAN-SCAFF, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

NAYIRI DOUDIKIAN-SCAFF, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 07/26/2006

NPI 1063435493

Primary specialty

Plastic Surgery Physician

Mid-sized

5,316 US NPIs in this specialty

Medicare Part D claims

384 357% vs specialty avg

2023 prescription claims

Specialty avg: 84

Specialty distribution in California

How Plastic Surgery Physician compares to other specialties among California providers

California providers

Plastic Surgery Physician share within California

1. Plastic Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Plastic Surgery Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Plastic Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Plastic Surgery Physician ABMS/AOA estimate

Est. board-certified rate (Plastic Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Plastic Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NAYIRI DOUDIKIAN-SCAFF, M.D. is a Plastic Surgery Physician provider practicing in PASADENA, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1063435493. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

NAYIRI DOUDIKIAN-SCAFF, M.D. appears in the CMS NPPES registry as a Plastic Surgery Physician provider holding M.D. credentials at 960 E GREEN ST, PASADENA, CA, 91106, with a listed phone of (626) 432-4600. NPI 1063435493 was issued on 07/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DOUDIKIAN-SCAFF most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 384 prescription claims written by this provider, covering 89 Medicare beneficiaries and totaling roughly $25K in drug spend, split 20% brand-name and 80% generic by claim count, with an opioid prescribing rate of 3.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Plastic Surgery Physician is a mid-sized specialty nationwide, with 5,316 enrolled providers across 52 states and an average of 84 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

960 E GREEN ST
PASADENA, CA 91106

Provider Details

NPI 1063435493
Specialty Plastic Surgery Physician
Credentials M.D.
Gender Female
NPI Issued 07/26/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NAYIRI DOUDIKIAN-SCAFF, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$245

Largest payer

Paratek Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to NAYIRI DOUDIKIAN-SCAFF, M.D.. To verify NAYIRI DOUDIKIAN-SCAFF, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

NAYIRI DOUDIKIAN-SCAFF, M.D. — brand share 20.0%
Specialty average (est.)

20% brand-name claims vs 80% generic, on 384 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

384
Total Claims
$25K
Total Drug Cost
89
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
399
Total Day Supply
8,103
Brand vs Generic
20% brand / 80% generic
Brand Drug Cost
$16K
Generic Drug Cost
$9K
Opioid Claims
13 (3.4% rate)
Antibiotic Claims
120

Patient Demographics

Average Patient Age
75.1 years
Avg HCC Risk Score
3.19
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Mupirocin
70
Doxycycline Hyclate
42
Gentamicin Sulfate
41
Santyl
Collagenase Clostridium Hist.
40
Cephalexin
26
Silver Sulfadiazine
22
Ciprofloxacin Hcl
15
Ssd
Silver Sulfadiazine
15
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
15
Nystatin
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Plastic Surgery Physician Overview

How NAYIRI DOUDIKIAN-SCAFF, M.D. fits within the Plastic Surgery Physician landscape nationally.

5,316
Plastic Surgery Physician Providers in US
52
States with Plastic Surgery Physician
84
Avg Claims per Provider

NAYIRI DOUDIKIAN-SCAFF, M.D.'s 384 claims are above the specialty average of 84.

Nearby Plastic Surgery Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as DOUDIKIAN-SCAFF.

Compare Plastic Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NAYIRI DOUDIKIAN-SCAFF, M.D.'s specialty?
NAYIRI DOUDIKIAN-SCAFF, M.D. specializes in Plastic Surgery Physician and practices in PASADENA, California. Credentials: M.D..
How much does NAYIRI DOUDIKIAN-SCAFF, M.D. prescribe under Medicare Part D?
In 2023, NAYIRI DOUDIKIAN-SCAFF, M.D. wrote 384 Medicare Part D claims totaling $25K in drug costs for 89 beneficiaries.
Where is NAYIRI DOUDIKIAN-SCAFF, M.D. located?
NAYIRI DOUDIKIAN-SCAFF, M.D. is located at 960 E GREEN ST, PASADENA, CA, 91106. Phone: (626) 432-4600.
What is NAYIRI DOUDIKIAN-SCAFF, M.D.'s NPI number?
NAYIRI DOUDIKIAN-SCAFF, M.D.'s National Provider Identifier (NPI) is 1063435493, issued on 07/26/2006.
Does NAYIRI DOUDIKIAN-SCAFF, M.D. prescribe more brand-name or generic drugs?
NAYIRI DOUDIKIAN-SCAFF, M.D.'s prescribing is 20% brand-name and 80% generic drugs by claim count, with $16K in brand drug costs.
Does NAYIRI DOUDIKIAN-SCAFF, M.D. prescribe opioids?
Yes, NAYIRI DOUDIKIAN-SCAFF, M.D. had 13 opioid claims in 2023 with an opioid prescribing rate of 3.4%.
How many Plastic Surgery Physician providers are there in the US?
There are 5,316 Plastic Surgery Physician providers across 52 states in the US. The average Plastic Surgery Physician provider writes 84 Medicare Part D claims per year.
What drugs does NAYIRI DOUDIKIAN-SCAFF, M.D. prescribe most often?
Based on 2023 Medicare Part D data, NAYIRI DOUDIKIAN-SCAFF, M.D.'s most frequently prescribed drugs include Mupirocin, Doxycycline Hyclate, Gentamicin Sulfate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NAYIRI DOUDIKIAN-SCAFF, M.D. accept Medicare?
NAYIRI DOUDIKIAN-SCAFF, M.D. appears in CMS Medicare data with 384 Part D claims and 89 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NAYIRI DOUDIKIAN-SCAFF, M.D.'s credentials?
NAYIRI DOUDIKIAN-SCAFF, M.D.'s NPI is 1063435493 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology